CompletedPhase 1ACTRN12607000611426

Phase Ia Pharmacokinetic and Tolerability Study of Oral NV-27 in Normal Healthy Volunteers

Sponsor

Novogen Research Pty Ltd

Enrollment

6 participants

Start Date

Dec 10, 2007

Study Type

Interventional

Conditions

Safety and tolerability of the investigational drug NV-27 in healthy male volunteers

Summary

This trial will involve 6 healthy male volunteers to determine the pharmacokinetics and safety/tolerability of the investigational drug NV-27.

Eligibility

Sex: MalesMin Age: 18 YearssMax Age: 40 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates phase Ia Pharmacokinetic and Tolerability Study of Oral NV-27 in Normal Healthy Volunteers. It is open to men only, aged 18 to 40. To join, participants should meet criteria including: a) Normal healthy male volunteers. People who have a) Participants who are on a concurrent investigational drug study or who have had any treatment ...

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

6 healthy male volunteers will each take 400mg of study drug NV-27 once, orally on day 1. The participants will be closely monitored for 5 days to determine the pharmacokinetics and tolerability of NV-27. Participants will then be required to return 4 weeks after taking NV-27 to assess their tolerability and the safety of NV-27.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000611426